Chikako Ichiki

A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats

Sachiko Kawasaki‐Yatsugi, Shin‐ichi Yatsugi, Masayasu Takahashi et al. · Brain Research · 1998 · 37 citations

Thrombosis, Cardiovascular Disease, Stroke +12

Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model

Sachiko Kawasaki‐Yatsugi, Chikako Ichiki, Shin‐ichi Yatsugi et al. · Neuropharmacology · 2000 · 36 citations

Cerebral Vascular Regulation, Health Sciences, Neurophysiology +14

Neuroprotective efficacy of YM872, an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in rats.

Masayasu Takahashi, Jian Wei Ni, Sachiko Kawasaki‐Yatsugi et al. · PubMed · 1998 · 33 citations

Pharmacotherapy, Single Ym872-administration, Cerebral Vascular Regulation +18

YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats

Sachiko Kawasaki‐Yatsugi, Chikako Ichiki, Shin‐ichi Yatsugi et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1998 · 20 citations

Ischemic Damage, Ampa Receptor Antagonist, Social Sciences +17

Neuroprotective Efficacy of YM872, an α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptor Antagonist, after Permanent Middle Cerebral Artery Occlusion in Rats

Masayasu Takahashi, Jian Wei Ni, Sachiko Kawasaki‐Yatsugi et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 16 citations